Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 2
2008 6
2009 9
2010 4
2011 6
2012 8
2013 10
2014 12
2015 12
2016 15
2017 20
2018 17
2019 10
2020 1
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis.
Chiricozzi A, Costanzo A, Fargnoli MC, Malagoli P, Piaserico S, Amerio P, Argenziano G, Balato N, Bardazzi F, Bianchi L, Carrera CG, Conti A, Dapavo P, De Simone C, Loconsole F, Lo Schiavo A, Malara G, Musumeci ML, Parodi A, Peris K, Prignano F, Rongioletti F, Talamonti M, Potenza C. Chiricozzi A, et al. Among authors: balato n. Eur J Dermatol. 2021 Feb 1;31(1):3-16. doi: 10.1684/ejd.2021.3965. Eur J Dermatol. 2021. PMID: 33648915 Review.
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study.
Megna M, Di Costanzo L, Argenziano G, Balato A, Colasanti P, Cusano F, Galluccio AG, Gambardella A, Lembo S, Mozzillo R, Scotto Di Luzio G, Fabbrocini G, Balato N. Megna M, et al. Among authors: balato n. Expert Opin Biol Ther. 2019 Aug;19(8):855-861. doi: 10.1080/14712598.2019.1622678. Epub 2019 May 29. Expert Opin Biol Ther. 2019. PMID: 31140882
Psoriasis Features in Patients with Inflammatory Bowel Disease.
Napolitano M, Testa A, Ferrillo M, Villani A, Balato N, Megna M, Nardone OM, Fabbrocini G, Castiglione F. Napolitano M, et al. Among authors: balato n. Open Access Maced J Med Sci. 2019 Mar 28;7(6):1001-1003. doi: 10.3889/oamjms.2019.161. eCollection 2019 Mar 30. Open Access Maced J Med Sci. 2019. PMID: 30976349 Free PMC article.
Secukinumab and hidradenitis suppurativa: Friends or foes?
Marasca C, Megna M, Balato A, Balato N, Napolitano M, Fabbrocini G. Marasca C, et al. Among authors: balato n. JAAD Case Rep. 2019 Jan 30;5(2):184-187. doi: 10.1016/j.jdcr.2018.12.002. eCollection 2019 Feb. JAAD Case Rep. 2019. PMID: 30740502 Free PMC article. No abstract available.
A multicenter retrospective case-control study on Suspension of TNF-inhibitors and Outcomes in Psoriatic patients (STOP study).
Stinco G, Balato N, Buligan C, Campanati A, Dastoli S, Di Meo N, Gisondi P, Lacarrubba F, Musumeci ML, Napolitano M, Offidani A, Pescitelli L, Piaserico S, Piccirillo A, Prignano F, Errichetti E. Stinco G, et al. Among authors: balato n. G Ital Dermatol Venereol. 2019 Aug;154(4):392-399. doi: 10.23736/S0392-0488.18.06156-4. Epub 2018 Sep 24. G Ital Dermatol Venereol. 2019. PMID: 30251810 Free article.
Treatment of Atopic Dermatitis with Biologic Drugs.
Fabbrocini G, Napolitano M, Megna M, Balato N, Patruno C. Fabbrocini G, et al. Among authors: balato n. Dermatol Ther (Heidelb). 2018 Dec;8(4):527-538. doi: 10.1007/s13555-018-0258-x. Epub 2018 Sep 4. Dermatol Ther (Heidelb). 2018. PMID: 30182182 Free PMC article. Review.
112 results